Joel Charles Cohen - Net Worth and Insider Trading

Joel Charles Cohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joel Charles Cohen owns 1 companies in total, including Intelgenx Technologies Corp (IGXT) .

Click here to see the complete history of Joel Charles Cohen’s form 4 insider trades.

Insider Ownership Summary of Joel Charles Cohen

Ticker Comapny Transaction Date Type of Owner
IGXT Intelgenx Technologies Corp 2006-04-28 director & CFO

Joel Charles Cohen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joel Charles Cohen Ownership Network

Ownership Network List of Joel Charles Cohen

No Data

Ownership Network Relation of Joel Charles Cohen

Insider Network Chart

Joel Charles Cohen Owned Company Details

What does Intelgenx Technologies Corp do?

Who are the key executives at Intelgenx Technologies Corp?

Joel Charles Cohen is the director & CFO of Intelgenx Technologies Corp. Other key executives at Intelgenx Technologies Corp include 10 percent owner Atai Life Sciences N.v. , 10 percent owner Atai Life Sciences Ag , and CEO Dwight Gorham .

Intelgenx Technologies Corp (IGXT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intelgenx Technologies Corp (IGXT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intelgenx Technologies Corp (IGXT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intelgenx Technologies Corp (IGXT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intelgenx Technologies Corp Insider Transactions

No Available Data

Joel Charles Cohen Mailing Address

Above is the net worth, insider trading, and ownership report for Joel Charles Cohen. You might contact Joel Charles Cohen via mailing address: 2800 Cote Vertu, #106, Montreal A8 H4r 2m5.

Discussions on Joel Charles Cohen

No discussions yet.